Abstract:The spike (S) and nucleocapsid (N) proteins, which are responsible for viral binding to cell surface receptors and the formation of ribonucleoprotein complexes during virion assembling, are major structure proteins of severe acute respiratory syndrome coronavirus (SARS-CoV). The expression of recombinant protein may give more accurate result for detecting SARS-CoV infection. A novel fusion protein,comprising of two fragments of N and S proteins from SARS-CoV, was prepared. Our computer-assisted analysis suggested that the immunodominant domains were located in the amino acid residues 1-227 of N protein and 450-650 of S protein, further the fusion of the two fragments did not change the immunochemical characteristics. The complementary DNA(cDNA) encoding N1-227 fused with S450-650 was obtained by sequence overlapping extension (SOE), and named NLS. It was cloned into pET-28a ( + ), an expression vector for His-tag fusion protein. This new constructed fusion protein was prokaryotic expressed in E. coli,and purified by metal chelate affinity chromatography with the purity over 95 %. The purified fusion protein was identified by anti-His monoclonal antibody and convalescence SARS patients serum. The NLS protein based ELISA showed that NLS maintained appropriate antigenicity and specificity to react with the sera of convalescent SARS patients. The functional NLS protein were successfully expressed and purified. And the fusion protein based ELISA can be used for detection of antibodies (Abs) against the S and N proteins of SARS-CoV. It may provided a novel diagnostic tool and have the potential application in developing of anti-SARS vaccine.

Prokaryotic Expression of SARS Coronavirus nsp8 Replicase

Cloning and Expression of Nsp14 Gene of SARS Coronavirus

The R Protein of SARS-CoV: Analyses of Structure and Function Based on Four Complete Genome Sequences of Isolates BJ01-BJ04

[Expression and Purification of Recombinant SARS Coronavirus Spike Protein].

Preparation and Preliminary Application of Recombinant Severe Acute Respiratory Syndrome Coronavirus (Sars-Cov) N Protein

Expression and Identification of SARS-CoV Nucleocapsid Protein

Expression, Purification and Antigen Analysis of SARS-associated Coronavirus Nucleocapsid Protein in Pichia Pastoris System

[Expression and Purification of Recombinant N-terminal Protein of SARS S1 Subunit Expressed in E. Coli].

Cloning, Expression, Purification of a Fusion Protein of SARS-CoV Nucleocapsid and Spike Protein Fragments and Its Immunological Characteristics

Cloning of SARS-CoV-S Gene and Construction of Its Short Interfering RNAs Expression Vector

The Expression and Purification of Truncated S Protein of SARS-CoV

Expression of Severe Acute Respiratory Syndrome(SARS) Virus S2 Protein in Pichia Pastoris

Molecular Cloning, Expression and Purification of the SARS Coronavirus Main Protease 3Clpro

Expression, purification and sublocalization of SARS-CoV nucleocapsid protein in insect cells.

The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoV antigenicity.

In Vitro Expression of SARS Coronavirus(sars-Cov)nucleocapsid Protein and Examination of the Function of Monoclonal Antibody Induced by the Expressed Protein

CLONING SEGMENT SPIKE PROTEIN GENE OF SARS-COV AND ITS EXPRESSION IN ESCHERICHIA COLI

Analysis of Nsp2 Expression in Porcine Reproductive and Respiratory Syndrome Virus Infected Cells

Construction of a Eukaryotic Expression Plasmid Encoding Partial S Gene Fragments of the SARS-CoV and Its Potential Utility As a DNA Vaccine

Expression and purification S protein of SARS-CoV

Expression of SARS Coronavirus Spike Protein in E. Coli and Silkworm Bombyx Mori